Formulary Search
A to Z of Drugs : B
Show Icon and Status Keys
- Bladder instillation
- Not Specified
- Oral solution
- Tablets
On advice from palliative care specialist team
- Oral solution
- Tablets
- Intrathecal injection
- Not Specified
This drug has not been assessed for inclusion on the formulary. Contact pharmacy for advice.
- Not Specified
- Tablets
- Tablets
MHRA risk JAK inhibitors - see PAD for details.
- Not Specified
- Tablets
- Not Specified
NHSE Specialist Centres only. Not a service that is provided by any of the Surrey Heartlands Acute Trusts.
- Not Specified
- Inhaler (Metered Dose)
Children only - ICS alone not recommended in adults with asthma.
First line ICS in children.
Prescribe by BRAND
- Inhaler (dry powder)
Not licensed in <18 years. ICS alone not recommended in adults with asthma.
Not to be initiated in new patients.
- Inhaler (breath actuated Metered Dose)
No dose counter, high carbon footprint.
Not for initiation in new patients.
- Inhaler (breath actuated Metered Dose)
No dose counter, high carbon footprint.
Not for initiation in new patients.
- Inhaler (Metered Dose)
Children only - ICS alone not recommended in adults with asthma.
Second line ICS in children (Clenil Modulite is 1st line).
No dose counter.
Prescribe by BRAND
- Nasal spray
Beclometasone 50mcg/dose (200 dose container) is recommended as a 1st line alternative treatment option. NOTE Beconase Hayfever and other container sizes (180 dose and 100 dose) are much more expensive and should not be used.
- Tablets (slow release)
Treatment of mild-moderate ulcerative colitis, as an add-on therapy to 5-ASA’s.
Steroid safety considerations
- Inhaler (dry powder)
Fostair NEXThaler 100/6
Prescribe by BRAND
- Inhaler (dry powder)
Fostair NEXThaler 100/6 - licensed from 18 years of age.
Not licensed for AIR.
Second line in adult asthma requiring MART. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
- Inhaler (dry powder)
Fostair NEXThaler 200/6 - High dose ICS/LABA for specialist* recommendation only.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
Not licensed for COPD.
Prescribe by BRAND.
- Inhaler (Metered Dose)
Not for initiation in new patients. Proxor device is the preferred beclometasone with formoterol pMDI.
Fostair 100/6, 200/6 not licensed in under 18 years. Not licensed for AIR.
Further information is being sought with regard to Proxor / Fostair bioequivalence. To be reviewed in Jul/Aug 2025.
- Inhaler (Metered Dose)
Not for initiation in new patients. Proxor device is the preferred beclometasone with formoterol pMDI.
Fostair 100/6 is not licensed in under 18 years. Not licensed for AIR.
Further information is being sought with regard to Proxor / Fostair bioequivalence. To be reviewed in Jul/Aug 2025.
- Inhaler (Metered Dose)
Proxor 100/6 - NEW device.
Fostair equivalent - Proxor is the most cost-effective ICS/formoterol pMDI. Licensed for MART in adults.
Prescribe by BRAND.
- Inhaler (Metered Dose)
Proxor 100/6 (new device) - licensed for MART in adults - second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
Not licensed in under 18 years.
Proxor is equivalent to Fostair and is the most cost-effective ICS/formoterol pMDI.
- Inhaler (Metered Dose)
Proxor 200/6 (new device) - higher dose ICS/LABA for specialist* recommendation only.
Not licensed in under 18 years. Not licensed for COPD
Proxor is equivalent to Fostair and is the most cost-effective ICS/formoterol pMDI.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
- Inhaler (Metered Dose)
Trimbow 87/5/9 (higher strengths not licensed for COPD)
Prescribe by BRAND
- Inhaler (dry powder)
- Inhaler (Metered Dose)
Trimbow 87/5/9 and 172/5/9 - specialist* recommendation only.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
- Tablets
- Not Specified
- Not Specified
- Not Specified
This drug has not been assessed for inclusion on the formulary. Please contact pharmacy for advice.
- Tablets
Only as add-on therapy for patients already on ezetimibe. Use the combination product (bempedoic acid with ezetimibe) in new patients.
- Tablets
- Tablets
- Tablets
- Not Specified
- Gel
Restricted for moderate/severe acne - only for monotherapy if combination products are contraindicated or patient wishes to avoid topical retinoid/antibiotic
Available OTC for mild acne.
- Wash gel
Restricted for moderate/severe acne - only for monotherapy if combination products are contraindicated or patient wishes to avoid topical retinoid/antibiotic
Available OTC for mild acne.
- Gel
5% benzoly peroxide wth clindamycin gel
- Gel
3% benzoyl peroxide with clindamycin
- Mouthwash
- Oromucosal spray
- Injection
- Effervescent tablets
On advice from specialist NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g. Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency
- Not Specified
- Tablets
- Not Specified
- Soluble tablets
- Injection
- Cream
- Ointment
Betamethasone dipropionate 0.05% (Diprosone) - Potent
- Cream
- Ointment
Betamethasone valerate 0.025% cream (Betnovate-RD) moderate potency
Betamethasone valerate 0.025% ointment (Betnovate-RD) moderate potency
- Cream
- Ointment
Betamethasone valerate 0.1% cream (Betnovate) - Potent
Betamethasone valerate 0.1% ointment (Betnovate) - Potent
- Foam
- Lotion
- Scalp application
Betamethasone valerate 0.1% scalp application (Betnovate / Betacap) - Potent
Betamethasone 0.1% foam (Bettamousse) - Potent
- Soluble tablets
- Nasal drops
- Ear drops
- Eye drops
- Eye ointment
- Cream
- Ointment
Potent. Compound preparation - usually for short term use - up to one week
- Betamethasone valerate 0.1% / Clioquinol 3% cream
- Betamethasone valerate 0.1% / Clioquinol 3% ointment
- Cream
Potent. Compound preparation - usually for short term up to one week
- Betamethasone dipropionate 0.064% / Clotrimazole 1% cream
- Cream
Potent. Compound preparation - usually for short term use - up to one week
- Betamethasone valerate 0.1% / Fusidic acid 2% cream
- Eye drops
- Cream
- Ointment
Potent. Compound preparation - usually for short term use - up to one week
- Betamethasone valerate 0.1% / Neomycin 0.5% cream
- Betamethasone valerate 0.1% / Neomycin 0.5% ointment
- Ear drops
- Ointment
- Scalp application
- Betamethasone dipropionate 0.05% / Salicylic acid 3% ointment
- Betamethasone dipropionate 0.05%/Salicylic acid 2% scalp application
- Eye drops
- Eye drops (preservative free)
- Tablets
Off-label use.
Palliative care only - RSFT
- Intravitreal injection
- Intravitreal injection
Avastin is not supported for use in wet AMD
- Intravitreal injection
- Modified release tablets
- Tablets
- Not Specified
- Not Specified
- Tablets
To be prescribed on recommendation from a specialist.
- Not Specified
- Not Specified
- Eye drops
- Eye drops
- Eye drops (preservative free
- unit dose)
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
- Subcutaneous injection (sc)
- Not Specified
- Subcutaneous injection (sc)
- Liquid
- Tablets
NHSE Specialist Commissioned Services only. Not commissioned from any Surrey Heartlands Trusts.
- Cartridges
- Pre-filled pen
- Cartridges
- Pre-filled pen
Prescribe by brand and state form.
- Cartridges
- Pre-filled pen
Prescribe by brand and state form.
- Not Specified
- Gel
- Suppositories
- Tablets
- Not Specified
- Gauze
- Paste
- Gauze
- Paste
- Tablets
- Tablets
- Tablets
- Tablets
- Intravenous infusion
- Not Specified
- Not Specified
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
- Injection
RSFT: For chronic anal fissure. If first dose unsuccessful refer for sphincterectomy
- Injection
- RSFT: Neurology Only
- SASH: Xeomin only
- Injection
Includes blepharospasm and hemifacial spasm. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.
- RSFT: Opthalmology and Neurology only. Dysport to be supplied to neurology if specifically requested
- SASH: Xeomin only
- Injection
- RSFT: Cerebral palsy paediatrics only.
- RSFT: Focal spasicitity: neurology, joint paediatric and orthopaedic team or care of the elderly
- SASH: Adults only
NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.
- Injection
RSCH - endoscopy only.
NOTE; different brands of botulinum toxin have difference licenses, please check SmPC
- Not Specified
Not assessed for formulary status. Contact pharmacy to make a formulary application.
- Not Specified
For Chronic migraine only.
- RSFT: Neurology only
- SASH: Botox only Neurology Only
- Injection
Focal dystonia, dystonic torticollis, cervical dystonia, spasmodic torticollis.
NOTE; different brands of botulinum toxin have difference licenses, please check SmPC
- RSFT: Neurology only. Dysport to be supplied to neurology if specifically requested
- Injection
RSFT: Pain Team only
- Injection
- RSFT: Urology Only
- SASH: Botox only. Urology Only
NOTE; different brands of botulinum toxin have difference licenses, please check SmPC
- Injection
NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.
RSFT: Opthalmology Only
- Injection
RSCH - endoscopy only.
NOTE; different brands of botulinum toxin have difference licenses, please check SmPC
- Injection
RSFT - Dr Walker’s team use only; 50 units/vial. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC
- Injection
- Eye drops
- Gel
- Eye drops
- Eye drops
- Eye drops
- Eye drops
- Oral solution
- Tablets
To be initiated by a specialist.
- Injection
- Not Specified
- Intravitreal injection
- Intravitreal injection
- Tablets
- Tablets
Cabergoline should be considered 1st-line. Initiation and supply of at least one month of treatment before transfer of prescribing to primary care. Monitoring remains the responsibility of secondary care in line with position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. https://pubmed.ncbi.nlm.nih.gov/30818417/
- Tablets
- Tablets
- Tablets
- Inhaler (dry powder)
Not for initiation in new patients.
- Inhaler (dry powder)
Children only - ICS alone not recommended in adults with asthma.
DPI licensed in children, cost effective.
Prescribe by BRAND.
- Inhaler (dry powder)
Children only - ICS alone not recommended in adults with asthma.
Licensed in children. Second line (Easyhaler budesonide device is preferred).
Prescribe by BRAND
- Nasal spray
Mometasone Furoate 50mcg/dose 140 dose container is the recommended 1st line treatment option. Budesonide is recommended as a 2nd line option
- Foam enema
- Modified release capsules
3mg MR capsules - specialist only
- Suppositories
Not assessed for formulary status. Applications for formulary entry via APC.
- Nasal spray
- Modified release capsules
Not interchangeable with other budesonide preparations.
This treatment is not provided by the Trusts in Surrey Heartlands but is on formulary at other local Trusts who provide renal services. Prescribing should remain with the specialist teams.
- Oro-dispersible tablets
- Oro-dispersible tablets
- Nebules
Specialist* recommendation following patient initiation and education on nebuliser therapy.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
- Nebules
Off-label use.
Paediatrics only.
- Nebules
Specialist recommendation following patient initiation and education on nebuliser therapy.
- Inhaler (dry powder)
DuoResp Spiromax 160/4.5 - licensed for AIR and MART from 12 years of age.
Second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
Prescribe by BRAND.
- Inhaler (dry powder)
DuoResp Spiromax 320/9 - higher dose ICS/LABA for specialist* recommendation only.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
Prescribe by BRAND.
- Inhaler (dry powder)
DuoResp Spiromax 160/4.5 - second line (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI).
Prescribe by BRAND.
- Inhaler (dry powder)
DuoResp Spiromax 320/9 - this strength is not recommended in the Surrey Heartlands COPD guidelines.
- Inhaler (dry powder)
Fobumix Easyhaler 80/4.5 and 160/4.5 - licensed in children.
Cost-effective choice for AIR and MART.
Prescribe by BRAND.
- Inhaler (dry powder)
Fobumix Easyhaler 320/9 - higher dose ICS/LABA for specialist* recommendation only.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
Prescribe by BRAND.
- Inhaler (dry powder)
Prescribe by BRAND.
- Inhaler (Metered Dose)
Symbicort 100/3 - For use in children. Useful for patients needing a pMDI licensed for MART.
Prescribe by BRAND
- Inhaler (Metered Dose)
Symbicort 200/6 - only for use if an MDI is needed.
- Inhaler (dry powder)
Symbicort Turbohaler 400/12 - second line (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
Prescribe by BRAND
- Inhaler (dry powder)
Symbicort Turbohaler 100/6 and 200/6 - Licensed for AIR and MART.
More costly device so second line option. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
Prescribe by BRAND.
- Inhaler (dry powder)
Symbicort Turbohaler 400/12 - higher dose ICS/LABA for specialist* recommendation only.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
Prescribe by BRAND
- Injection
- Oral solution
- Tablets
- Injection
- Implant
Buprenorphine implant has not been assessed for inclusion on the formulary. Please contact Pharmacy for advice.
- Patches
Prescribe by brand. Care: available as 3-day, 4-day and 7-day patches. Refer to Trust / Primary Care Pharmacy advice for locally preferred brands
- Sublingual tablets
- Tablets
Patients who are established on this treatment for depression, and have been receiving prescriptions in Primary Care, may continue to do so.
- Nasal spray
- Subcutaneous injection (sc)